Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Apathy Using Attentional Reaction Test in Neurodegenerative Diseases
This study is currently recruiting participants.
Verified by Centre Hospitalier Universitaire de Nice, April 2009
First Received: January 28, 2009   Last Updated: April 15, 2009   History of Changes
Sponsored by: Centre Hospitalier Universitaire de Nice
Information provided by: Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier: NCT00833274
  Purpose

Apathy, defined as a lack of motivation in behaviour, cognition and affect, is common in neurodegenerative diseases. Specific scales are available for the evaluation of apathy but it lacks objective evaluation methods. The aim of this study is to evaluate the changes in reaction time task according to the presence or absence of reward stimulation and to assess the relation between these performances and apathy scales.


Condition Intervention
Alzheimer Disease
Behavioral: computerized test

Study Type: Interventional
Study Design: Diagnostic, Open Label, Uncontrolled, Parallel Assignment
Official Title: Evaluation of Apathy Using Attentional Reaction Test in Neurodegenerative Diseases

Resource links provided by NLM:


Further study details as provided by Centre Hospitalier Universitaire de Nice:

Primary Outcome Measures:
  • Reaction times (ms), using a computerized test [ Time Frame: one time point, at day 0 (day of inclusion) during the computerized test ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Apathy severity, using a specific apathy scale (Apathy Inventory) [ Time Frame: one time point, at day 0 (day of inclusion), during the visit ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: February 2009
Estimated Study Completion Date: May 2010
Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Using a computerized test, each patient is asked to press a button (mouse of the computer) each time the screen of the computer becomes completely white.
Behavioral: computerized test
Using a computerized test, each patient is asked to press a button (mouse of the computer) each time the screen of the computer becomes completely white.

Detailed Description:

MATERIAL: 13 patients with Mild Cognitive Impairment (MCI), 15 patients with Alzheimer's disease (AD) and 91 elderly healthy subjects were enrolled. A computerized test using the experiment software E-prime® was designed to assess reaction times (in ms) in different experimental conditions after a training trial (neutral, stimulation, stress, stimulation after stress, extinction) and relation between the performances to the test and the Apathy Inventory (AI) scores (lack of initiative, lack of interest, emotional blunting) were observed. METHOD: Using a computerized test, each patient is asked to press a button (mouse of the computer) each time the screen of the computer becomes completely white. After pressing the button, a randomized colorized geometric figure appears on the screen, and disappears automatically after a few seconds, replaced by a new white screen.

Reaction time (in ms) between a white screen and a press of the button is analysed. After a training trial, reaction times are analysed in different experimental conditions: neutral - stimulation1 (patient gets points when pressing the button) - stress (alarm) - stimulation2 (patient gets points when pressing, after the stress trial) - extinction (similar to neutral condition).

  Eligibility

Ages Eligible for Study:   65 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Elderly patients with diagnosis of Alzheimer's Disease according to DSM-IV criteria
  • MMSE >20

Exclusion Criteria:

  • None
  • Motor or psychiatric disorders
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00833274

Contacts
Contact: Philippe ROBERT, MD, PhD 0492034770

Locations
France
CM2R, Nice University Hospital Recruiting
NICE, France, 06000
Contact: Philippe ROBERT, MD,PhD         robert.ph@chu-nice.fr    
Contact: Renaud DAVID, MD         david.r@chu-nice.fr    
Principal Investigator: Philippe ROBERT, MD, PhD            
Sub-Investigator: Renaud DAVID, MD            
Sponsors and Collaborators
Centre Hospitalier Universitaire de Nice
  More Information

No publications provided

Responsible Party: CHU de Nice ( Departement de la Recherche Clinique et de l'Innovation )
Study ID Numbers: 06-CIR-01
Study First Received: January 28, 2009
Last Updated: April 15, 2009
ClinicalTrials.gov Identifier: NCT00833274     History of Changes
Health Authority: France: Direction Générale de la Santé;   France: French Data Protection Authority;   France: Institutional Ethical Committee

Study placed in the following topic categories:
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Alzheimer Disease
Central Nervous System Diseases
Brain Diseases
Dementia
Neurodegenerative Diseases
Cognition Disorders
Delirium

Additional relevant MeSH terms:
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Nervous System Diseases
Alzheimer Disease
Central Nervous System Diseases
Tauopathies
Brain Diseases
Dementia
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on August 28, 2009